{"i would not say \"there is no reason to adjust...\"
6-mercaptopurine can be affected by a patient's TPMT and NUDT15 phenotype. This patient is predicted to be a TPMT normal metabolizer. Based on that specific result, the patient may receive a standard starting dose of 6-mercaptopurine. However, a NUDT15 genotype does not appear to have been ordered for this patient, and it is not known if NUDT15 results would further influence the recommended dose or drug. Monitor closely for toxicity. Please consult a clinical pharmacist for more information."}